date,title,source
Oct-17-18,"Iovance Biotherapeutics, Inc. Announces Closing of $252 Million Common Stock Public Offering",GlobeNewswire
Oct-18-18,Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe,GlobeNewswire
